Advertisement

Topics

FDA awards orphan drug status to brain cancer vaccine

05:42 EDT 9 Aug 2017 | ecancermedicalscience

The U.S. Food and Drug Administration has awarded orphan drug status to a promising immunotherapy vaccine, SurVaxM. Orphan status is a special designation awarded to encourage innovation and exploration of approaches to treat rare diseases that affect...

Original Article: FDA awards orphan drug status to brain cancer vaccine

NEXT ARTICLE

More From BioPortfolio on "FDA awards orphan drug status to brain cancer vaccine"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...